Introduction

Abdominoperineal resection has been the gold standard surgery for many anorectal malignancies since its description in 1908 [1]. Perineal reconstruction with plastic surgery techniques is an important adjunct to oncologic surgery and allows for more aggressive tumor resection [2]. It is commonly agreed that successful perineal reconstruction is achieved through the elimination of perineal dead space, obliteration of the defect with healthy, well-vascularized tissue, and a tension-free closure. In patients undergoing abdominoperineal resection, perineal reconstruction with a myocutaneous flap yields better local outcomes compared to primary cutaneous closure [3,4,5]. There are several flap-based perineal reconstruction techniques, broadly divided into abdominal-based (such as rectus abdominis), thigh-based (such as gracilis or anterolateral thigh), and perineal-based (such as gluteal) approaches, none of which has been proven to have superior outcomes [6, 7].

In our institution, we have used a perineal-based approach, namely the myocutaneous gluteal flap, for reconstruction of medium-sized perineal defects for almost two decades, whereas for the reconstruction of large perineal defects, we use a vertical rectus abdominis muscle (VRAM) flap [2]. The VRAM flap is a well-established method for perineal reconstruction and allows plenty of bulk for the elimination of perineal dead space as well as tension-free closure; however, it carries a 15–17% risk of donor-site morbidity, and the pedicled design brings a 23–27% risk of perineal flap morbidity, and the risk of complete flap loss is small (2%) but present [8,9,10].

Our rationale behind using the myocutaneous gluteal flap reconstruction technique in medium-sized defects are its advantages of prone positioning of the patient, and lower donor-site morbidity compared to the VRAM flap, whereas the disadvantage is a higher risk of prolonged perineal healing and possibly a greater risk of long-term complications including perineal hernias due to poorer elimination of perineal dead space [11, 12]. The higher risk of perineal wound dehiscence may or may not be related to the increased frequency of neoadjuvant radiotherapy in this patient group. With the myocutaneous gluteal flap reconstruction technique, perineal post-operative morbidity affects 42% of patients [2, 11].

In the last few years, another perineal-based approach, the fasciocutaneous V–Y flap, has been described by several teams as a timely, safe, and efficient reconstructive approach for perineal defects [13,14,15,16]. Similar to the myocutaneous gluteal flap, the V–Y fasciocutaneous flap allows for prone positioning of the patient, and avoids morbidity of the abdominal wall, but has the additional advantage of being muscle-sparing. Patients undergoing gluteal flap–based reconstructive breast surgery have reported gait and ambulation problems both during the early and in the late post-operative period [17]. Post-operative mobilization is often limited by pain and tightness following the muscle flap reconstruction, further contributing to a long post-operative rehabilitation and potentially additional complications. In comparison to the myocutaneous gluteal flap, the V–Y flap could thus be hypothesized to offer a quicker dissection and flap mobilization, fewer post-operative complications, and an easier post-operative rehabilitation.

The potential disadvantage with the thinner fasciocutaneous V–Y flap, on the other hand, could be an increased risk of long-term perineal complications such as hernias. To our knowledge, no prospective or retrospective study has compared the myocutaneous flap with the fasciocutaneous option for perineal reconstruction after abdominoperineal oncologic resection.

In our unit, as of December 2018, patients who after abdominoperineal resection have pelvic floor defects too large for primary muscle closure, as jointly assessed by the colorectal and reconstructive plastic surgeons, are reconstructed with a V–Y fasciocutaneous flap [2]. We compare clinical outcomes and post-operative complications between the previously employed myocutaneous gluteal flap and the recently implemented fasciocutaneous V–Y flap for perineal reconstruction.

Materials and methods

We performed a retrospective observational cohort study of all patients who underwent abdominoperineal resection and perineal reconstruction with a unilateral perineal-based flap at Karolinska University Hospital between 1st January 2016 and 31st December 2019.

This study was performed in line with the principles of the Declaration of Helsinki. The Swedish Ethical Review Authority approved the study (reference number 2019–04636) and confirmed that no written consent was required for this observational study. The authors affirm that human research participants provided informed consent for publication of the images in Figs. 1AD and 2AD.

Patients were identified through a search in the electronic medical records for referrals between the colorectal unit and the reconstructive plastic surgery unit, since such a referral is the formal way of enlisting reconstructive competency in anticipation of an extended abdominoperineal resection. The choice of reconstructive method was at the discretion of the plastic surgeon and consisted of either a gluteal musculocutaneous flap (mainly 2016–2017) or a V–Y fasciocutaneous flap (mainly 2018–2019). For a typical size defect, please see Fig. 1A (Supplemental Online Material).

Patient demographics and comorbidities, indication for surgery, treatment data, and post-operative outcomes were all collected from electronic medical records. Patient data included sex, age, smoking habits, BMI, pre-operative serum albumin levels, and comorbidities such as diabetes, and ASA classification (American Society of Anesthesiologists Physical Status). Treatment data included tumor type, the use of neoadjuvant radiotherapy, and surgical approach. Data on reconstructive procedure duration, through the operating room electronic medical record, and tumor size, as stated by the pathology report, was also collected.

All post-operative complications were recorded. There were divided into any wound dehiscence, bleeding from the surgical site, local or systemic infection, partial or full flap necrosis, take-back to theater for flap-related reasons, re-admittance after discharge for flap-related complications, and perineal hernias. Complications were categorized as short-term (within 30 days of surgery) or long-term complications. Complications were further divided into systemic and local (flap or perineal) complications, the latter category including wound dehiscence, perineal surgical site infection, and flap necrosis. Systemic infections considered to have originated in perineal infections were classified as local, flap-related complications, whereas systemic infections without known source were classified as systemic complications. Post-operative rehabilitation factors recorded were time to ambulant mobility, defined as walking at least 10 m without human support as per the physiotherapists’ records, time to removal of perineal wound drains, time to removal of epidural pain catheter, and time to discharge from the university hospital to either the patient’s home, a rehabilitative unit, or a regional hospital. Patients were followed for as long as medical records were available, or until end-of-follow-up in September 2020.

Exclusion criteria were reconstruction with bilateral flaps instead of unilateral flaps, and concurrent vaginal reconstruction through an additional or extended flap. A STROBE checklist is supplied as supplementary material.

Surgical methods

All flaps were raised at the end of the abdominoperineal resection with the patient in a prone position. The gluteal musculocutaneous flap was marked on the skin as a cranially based rotational flap in a manner that has been described previously (Fig. 1, Supplemental Online Material) [2, 11]. The skin, the subcutaneous tissue, and the gluteus maximus fascia were incised all along the wound, after which one-third to half of the gluteus maximus muscle was divided from its medial border laterally. The medial border of the contralateral gluteus maximus muscle was identified. The musculocutaneous flap was raised until it reached the contralateral muscle without tension. The flap was sutured in four layers with interrupted sutures in the muscle, followed by interrupted or uninterrupted sutures in both the Scarpa’s fascia and the deep dermis, and finally interrupted non-absorbable sutures in the skin.

The fasciocutaneous flap was marked on the skin as a laterally based V–Y flap (Fig. 2, Supplemental Online Material). The skin, the subcutaneous tissue, and the gluteus maximus fascia were incised to provide mobility, followed by de-epithelization of 4–5 cm of the medial border. The de-epithelized tissue was sutured to the levator ani muscle if not resected in the abdominoperineal resection, otherwise and most often to the contralateral border of the gluteus maximus muscle. The flap was sutured in four layers with interrupted sutures between the de-epithelized tissue and the muscle, followed by interrupted or uninterrupted sutures in both the Scarpa’s fascia and the deep dermis, and finally interrupted non-absorbable sutures in the skin.

Post-operative regimen

The post-operative protocol was constructed in collaboration with colorectal surgeons and physiotherapists, and printed versions were available on the ward. The post-operative regimen for both surgical techniques included care in an air-fluidized therapy bed until discharge, avoidance of on-the-side positioning on the flap-side until the second post-operative day, two active wound drains, and removal of sutures at 21 days post-operatively. Drains were removed when producing less than 50 ml per drain per day, and at the earliest 24 h after removal of the abdominal or pelvic drains placed by the colorectal surgeons. Epidural catheters were used in all patients and were post-operatively gradually replaced with oral pain medication as needed. For both techniques, careful, step-wise mobilization of the patient was guided by physiotherapists, and sitting with 90° hip flexion was not allowed until 15 days post-operatively and then only for 30 min at a time. Step-wise mobilization was guided by patient pain and capacity, and ambulant mobility, initially with the help of human support or a walking frame, was encouraged to take place as early as possible. For patients operated with the gluteal musculocutaneous flap, hip flexion was kept below 45° until post-operative day 8, whereas for patients operated with the fasciocutaneous flap, hip flexion up to 60° was allowed from the first post-operative day, and the technique for physiotherapist-supported uprising from bed to standing position was adjusted accordingly.

Statistical analysis

Patient characteristics, management details, and outcomes were described using frequencies (in per cent), means, and ranges. Differences in post-operative outcomes were analyzed by type of reconstructive surgery. The Fisher exact test was used for categorical variables whilst the Mann–Whitney U test was employed for continuous variable analysis. Statistical analysis was carried out using Stata version 13.1. A p-value ≤ 0.05 was considered statistically significant.

Results

We identified 54 patients who had undergone abdominoperineal resection with perineal flap reconstruction during the study time. Ten patients were excluded on the basis of having had a bilateral flap reconstruction (five patients) or having had a concurrent vaginal reconstruction (five patients).

In total, 44 patients were included in our analysis (Table 1). A majority (32 patients, 72.7%) of the cohort were men. The mean age at surgery was 65.3 years (range 42–78 years). Two-third of patients (29 patients, 65.9%) had never been smokers, and diabetes was uncommon (8 patients, 18.2%). Mean BMI in the cohort was 26.0, and 20 patients (45.5%) had a low serum albumin, defined as below 33 g/L. A majority of patients (40 patients, 91%) were classified pre-operatively as ASA II or III. The indication for surgery was a locally advanced rectal malignancy resected with extralevator abdominoperineal excision (ELAPE) in 39 patients, a locally advanced anal cancer in three patients, and other (inflammatory bowel disease and suspected but not confirmed malignancy) in two patients. Seventeen patients (38.6%) were treated for a recurrent cancer, and thus underwent abdominoperineal resection for their second time. Most patients (90.9%) had previous radiotherapy.

Table 1 Characteristics of the study population. Patients undergoing perineal reconstruction after abdominoperineal resection between 2016 and 2019

The mean age was lower (63 years vs 67 years), and the mean BMI was higher (27 versus 25) in the cohort reconstructed with a musculocutaneous flap, but the differences were not statistically significant (p = 0.193, p = 0.169). The indication for surgery was rectal cancer in 78.9% of the cohort reconstructed with a musculocutaneous flap and 96.0% in the cohort reconstructed with a fasciocutaneous flap. All other patient characteristics were similar between the cohorts.

The mean duration of the perineal reconstruction was 116 min in the entire cohort (range 62–165 min, standard deviation (SD) 31). The mean duration of the fasciocutaneous V–Y flap reconstruction was slightly longer, 125 min, compared to the musculocutaneous flap reconstruction, 108 min, but the difference was not statistically significant (p = 0.105). Flap drains were kept for 8 days post-operatively on average (range 2–18 days, SD 3) and the epidural catheter for 7 days (range 4–13 days, SD 2). Patients were ambulant after 6 days on average (range 2–16 days, SD 3), and discharged from the hospital after a mean inpatient time of 13 days (range 5–37 days, SD 7). There was no difference between the two groups in time to drain removal, time to epidural removal, time to ambulant mobility, or inpatient time.

The incidence of any post-operative complication within 30 days was 70.5% in the entire cohort (Table 2). The incidence of flap-related complications was 38.6% in the cohort (Tables 2 and 3). Six patients (13.4%) required take-back to theater for flap-related reasons, four in the musculocutaneous flap group and two in the fasciocutaneous V–Y flap group. There was no difference in incidence of all complications (p = 0.797), in flap-related complications (p = 0.831), or in specific complications between the groups.

Table 2 Post-operative complications. Patients undergoing perineal reconstruction after abdominoperineal resection between 2016 and 2019
Table 3 Post-operative flap-related complications within 30 days. Patients undergoing perineal reconstruction after abdominoperineal resection between 2016 and 2019

Ten patients in the cohort (22.7%) had complications that persisted after 30 days or occurred after 30 days, and half of these were flap-related (late wound dehiscence and/or perineal or flap infection). Late complications, occurring after more than 6 months, were identified in four patients in the musculocutaneous flap group (21.1%) and one patient in the fasciocutaneous flap group (4.0%), and consisted of persisting wound healing problems in three patients and perineal hernias in two patients, the latter both in the musculocutaneous flap group. Mean follow-up time was 9 months (range 1–32 months, SD 9), with a shorter follow-up time in the fasciocutaneous flap group compared to the musculocutaneous flap group (6 months and 12 months respectively, p = 0.092).

When looking only at the 39 ELAPE patients, we found a lower rate of flap-related complications in the group reconstructed with a fasciocutaneous flap (10 out of 24 patients, 41.7%) compared to the group reconstructed with a musculocutaneous flap (7 out of 15 patients, 46.7%), but this difference was not statistically significant (p = 0.509). The results of other analyses were the same (output not shown).

Discussion

In this retrospective cohort study of 44 patients, we reviewed the post-operative outcomes after two surgical methods of perineal reconstruction after abdominoperineal resection. We found no certain differences in post-operative rehabilitation or in complications in the two groups reconstructed with either a fasciocutaneous V–Y flap or a musculocutaneous gluteal flap.

The fasciocutaneous V–Y flap was introduced in our department in 2018, and we hypothesized it to be a quicker and safer perineal reconstruction method than the musculocutaneous gluteal flap. However, in this analysis, we were unable to detect a difference in operating time, rehabilitation time, or overall post-operative complications. We found an overall incidence of perineal post-operative complications of 39%, comparable to the previously described incidence of 42% for the musculocutaneous gluteal flap [2, 11]. Our results are similar to previously reported incidences of post-operative complications after the fasciocutaneous V–Y flap, ranging from 42 to 45% [13,14,15].

When looking only at ELAPE patients, we detected a lower rate of flap-related complications in the group reconstructed with a fasciocutaneous V–Y flap compared to the group reconstructed with a musculocutaneous flap. This difference was not statistically significant, which suggests the difference is due either to chance, or to a lack of power disguising a true difference in post-operative complication rates after perineal reconstruction in ELAPE patients, where the fasciocutaneous V–Y flap is more advantageous. This will need to be confirmed by analysis of more patients. The thinner, fasciocutaneous V–Y flap can be assumed to less effectively eliminate perineal dead space, and therefore increase the risk of for example seroma collections, but this was not reflected in our data.

Late complications, including persisting wound healing problems and perineal hernias, were identified in four patients in the musculocutaneous flap group and one patient in the fasciocutaneous flap group. However, the mean follow-up time was shorter in the fasciocutaneous flap group, since this is the newly introduced surgical approach, and thus we cannot conclude with certainty from this data that long-term complications are more common after reconstruction with the musculocutaneous gluteal flap compared to the fasciocutaneous V–Y flap. Since our center is a nationwide referral center for the treatment of advanced colorectal cancer, a majority of our patients are discharged to follow-up at their regional cancer centers, which is why our follow-up in this study is often very short. This means that, possibly, late complications may not be brought to our knowledge unless the patient has severe issues and is referred back to us, which makes our data on long-term complications unreliable. To our knowledge, only one previous study has examined the long-term complications after the fasciocutaneous V–Y flap, and detected two perineal hernias in their group of 38 ELAPE patients reconstructed with different approaches [15]. This underlines the need for more long-term follow-up and evaluation after perineal reconstruction.

This is to our knowledge the first study to compare, in the same unit, the musculocutaneous gluteal flap to the fasciocutaneous V–Y flap for perineal reconstruction after abdominoperineal reconstruction. One of the strengths of this study is the similarity between the two groups compared, with very similar patient characteristics, and treatment by the same colorectal and plastic surgery teams, respectively. Limitations include the retrospective study design, and the short follow-up times in relation to long-term complications. As a national cancer center, many of our patients are from outside the Stockholm region, making follow-up difficult. Long-term complications in both groups might have been managed in regional hospitals without being detected by us.

As our results clearly show, post-operative complications after abdominoperineal resection with perineal reconstruction affect many patients, and several factors other than the reconstructive surgery approach are likely to influence the post-operative complication rate. These include for example the extensiveness and duration of the abdominoperineal resection, the experience of the reconstructive plastic surgeon, and other variables which we were unable to control for in this analysis. It is possible that the surgical approach of perineal reconstruction matters little in relation to other variables in this high-morbidity procedure, in which case both examined reconstructive methods are equivalent. It is now more common than not that patients undergoing ELAPE have had prior radiotherapy, and it is worth noting that the local, perineal-based approach we use in both surgical techniques thus works well in this patient group.

In conclusion, our study shows that both a fasciocutaneous and a musculocutaneous flap are acceptable options for perineal reconstruction. Our data suggests that the fasciocutaneous V–Y flap might yield slightly fewer local complications in ELAPE patients, but this needs to be examined further, especially concerning the long-term outcomes.